Nagasaki, Japan

Kiyoshi Osatomi

This inventor holds 3 USPTO granted patents. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyoshi Osatomi. Retrieved from https://idiyas.com/inventor/kiyoshi-osatomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Kumamoto, JP (1998)
  • Nagasaki, JP (1998 - 2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kiyoshi Osatomi: Innovator in Anti-HIV Research

Introduction

Kiyoshi Osatomi is a notable inventor based in Nagasaki, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of anti-HIV therapies. With a total of 3 patents to his name, Osatomi's work is recognized for its potential impact on public health.

Latest Patents

Among his latest patents is the innovative "Anti-HIV monoclonal antibody" and the "Recombinant anti-HIV antibody and process for preparing the same." These patents reflect his commitment to advancing medical science and providing solutions to combat HIV.

Career Highlights

Kiyoshi Osatomi is affiliated with the Chemo-Sero-Therapeutic Research Institute, where he conducts his research. His work at this institute has positioned him as a key figure in the fight against HIV, contributing to the development of effective treatments.

Collaborations

Osatomi has collaborated with esteemed colleagues, including Kouichi Shiosaki and Yasuyuki Eda. These partnerships have enhanced his research efforts and fostered innovation in the field.

Conclusion

Kiyoshi Osatomi's contributions to anti-HIV research exemplify the vital role of inventors in advancing medical science. His patents and collaborations highlight the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…